Non-Current Assets
Other intangible assets—net
Biogen Other intangible assets—net decreased by 1.4% to $9.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from $9.58B to $9.05B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows an upward trend with a 24.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase typically follows acquisitions, while a steady decrease reflects ongoing amortization of existing intangible assets.
Detailed definition
This represents the net book value of identifiable non-physical assets such as acquired technology, patents, customer li...
Peer comparison
Standard for companies that grow through M&A, often labeled 'Intangible assets, net'.
Metric ID:
non_current_assets_intangible_assets_net_excluding_goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $2.29B | $2.22B | $2.15B | $2.08B | $2.01B | $1.85B | $1.81B | $1.78B | $7.34B | $8.36B | $8.28B | $8.23B | $9.81B | $9.69B | $9.58B | $9.47B | $9.33B | $9.18B | $9.05B |
| QoQ Change | — | -4.1% | -2.9% | -3.2% | -3.5% | -3.2% | -7.9% | -2.0% | -2.0% | +313.5% | +13.9% | -0.9% | -0.6% | +19.1% | -1.2% | -1.1% | -1.2% | -1.4% | -1.6% | -1.4% |
| YoY Change | — | — | — | — | -13.0% | -12.2% | -16.7% | -15.7% | -14.4% | +265.6% | +352.0% | +356.9% | +363.5% | +33.5% | +15.9% | +15.7% | +15.0% | -4.8% | -5.3% | -5.5% |
Range$1.78B – $9.81B
CAGR+32.4%
Avg YoY Growth+83.2%
Median YoY Growth+5.1%
Current Streak6 quarters decline
Other intangible assets—net at Other Companies
Frequently Asked Questions
- What is Biogen's other intangible assets—net?
- Biogen (BIIB) reported other intangible assets—net of $9.05B in Q1 2026.
- How has Biogen's other intangible assets—net changed year-over-year?
- Biogen's other intangible assets—net decreased by 5.5% year-over-year, from $9.58B to $9.05B.
- What is the long-term trend for Biogen's other intangible assets—net?
- Over 5 years (2020 to 2025), Biogen's other intangible assets—net has grown at a 24.4% compound annual growth rate (CAGR), from $3.08B to $9.18B.
- What does other intangible assets—net mean?
- The value of non-physical assets like patents and acquired technology, excluding goodwill.